摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-甲氧羰基苯硼酸频哪醇酯 | 653589-95-8

中文名称
2-甲氧羰基苯硼酸频哪醇酯
中文别名
2-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)苯甲酸甲酯;2-(甲氧基羰基)苯硼酸(4,4,5,5-四甲基乙二醇)酯
英文名称
methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
英文别名
methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolane-2-yl)benzoate;2-methoxycarbonylphenylboronic acid pinacol ester;2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid methyl ester;methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolyl)benzoate
2-甲氧羰基苯硼酸频哪醇酯化学式
CAS
653589-95-8
化学式
C14H19BO4
mdl
——
分子量
262.113
InChiKey
GWSGJWIUSIAFOP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    49-51°C
  • 沸点:
    363.7±25.0 °C(Predicted)
  • 密度:
    1.08±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.77
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    44.8
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 危险品标志:
    Xi
  • WGK Germany:
    3
  • 海关编码:
    2934999090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    2-8℃

SDS

SDS:a7c701e7c2e0750541c3b92907f91a12
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Methoxycarbonylphenylboronic acid, pinacol ester
Synonyms: Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Methoxycarbonylphenylboronic acid, pinacol ester
CAS number: 653589-95-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H19BO4
Molecular weight: 262.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-甲氧羰基苯硼酸频哪醇酯四(三苯基膦)钯 、 sodium carbonate 、 lithium hydroxide 作用下, 以 四氢呋喃甲醇乙二醇二甲醚 为溶剂, 生成 4-三氟甲基-联苯-2-甲酸
    参考文献:
    名称:
    [EN] SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS
    [FR] HYDANTOÏNAMIDES SUBSTITUÉS UTILISÉS EN TANT QU'ANTAGONISTES D'ADAMTS7
    摘要:
    本申请涉及式(I)所示的取代脒酰胺作为ADAMTS7拮抗剂,涉及它们的制备过程,以及它们单独或组合用于治疗或预防疾病,特别是心血管疾病,包括动脉粥样硬化、冠心病(CAD)、外周血管病(PAD)、动脉闭塞性疾病或血管成形术后的再狭窄。R1是氢、烷基、环烷基、杂环烷基、杂芳基或苯基;R2是氢、氰基、卤素、烷基亚磺酰基、烷基、环烷基或烷氧基;R3、R4、R5、R6、R7和R8独立的是氢、卤素、烷基或烷氧基;大多数基团可被选择性地取代;条件是至少R2、R3、R4中的一个为H;X1、X2、X3、X4、X5和X6独立的是N或C;条件是每个环中最多只有一个X是N。
    公开号:
    WO2021094436A1
  • 作为产物:
    描述:
    苯甲酸 在 (1,5-cyclooctadiene)(methoxy)iridium(I) dimer 、 硫酸5,5'-二(三氟甲基)-2,2'-联吡啶 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 17.5h, 生成 2-甲氧羰基苯硼酸频哪醇酯
    参考文献:
    名称:
    5-三氟甲基化联吡啶配体实现的铱催化芳族酰胺的邻位选择性硼酸化
    摘要:
    仅仅在联吡啶配体的 5 位引入 CF 3基团就促进了铱催化的苯甲酰胺和衍生物的硼酸化反应中区域选择性的显着变化,从间位/对位取代到邻位取代。计算和实验数据表明,这种效应与底物的羰基和配体的CF 3 -bipy 环之间不寻常的外球色散相互作用有关。
    DOI:
    10.1002/anie.202214510
点击查看最新优质反应信息

文献信息

  • A new air-stable Si,S-chelating ligand for Ir-catalyzed directed <i>ortho</i> C–H borylation
    作者:Jiao Jiao、Wenzheng Nie、Peidong Song、Pengfei Li
    DOI:10.1039/d0ob02335c
    日期:——
    reaction with a broad substrate scope. This study provides the first example of using a sulfur-containing ligand in the catalytic C–H borylation process. It provides a rapid, efficient, and economical method for the preparation of organoboron compounds.
    已开发出一种新型的空气稳定的Si,S螯合配体,并用于具有广泛底物范围的铱催化的邻位C-H硼酸酯化反应中。这项研究提供了在催化C–H硼化过程中使用含硫配体的第一个例子。它提供了一种快速,有效和经济的有机硼化合物的制备方法。
  • [EN] NOVEL N-[(PYRIMIDINYLOXY)PROPANYL]BENZAMIDES<br/>[FR] NOUVEAUX N-[(HÉTÉROARYLOXY)PROPANYL]HÉTÉROARYL CARBOXAMIDES
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2017178338A1
    公开(公告)日:2017-10-19
    This invention relates to compounds of formula (I), a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar, R1, R2, R3, R4, R5 have meanings given in the description.
    这项发明涉及到式(I)的化合物,其制备方法,含有它们的药物组合物以及它们在治疗与促觉醒素亚型1受体相关的疾病中的应用。Ar,R1,R2,R3,R4,R5的含义如描述中所示。
  • [EN] NOVEL N-[(PYRAZINYLOXY)PROPANYL]BENZAMIDES<br/>[FR] NOUVEAUX N-[(PYRAZINYLOXY)PROPANYL]BENZAMIDES
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2017178339A1
    公开(公告)日:2017-10-19
    This invention relates to compounds of formula (I) a process for their preparation, pharmaceutical compositions containing them and their use in the treatment of conditions having an association with the orexin sub-type 1 receptor. Ar, R1, R2 and R3 have meanings given in the description.
    这项发明涉及式(I)的化合物,其制备方法,含有它们的药物组合物以及它们在治疗与促觉肽亚型1受体相关的疾病中的应用。Ar、R1、R2和R3的含义如描述中所示。
  • Palladium nanoparticle catalysis: borylation of aryl and benzyl halides and one-pot biaryl synthesis via sequential borylation-Suzuki–Miyaura coupling
    作者:Ansuman Bej、Dipankar Srimani、Amitabha Sarkar
    DOI:10.1039/c2gc16111g
    日期:——
    catalyze the reaction of bis(pinacolato)diboron with various aryl/benzyl halides to afford aryl/benzyl boronates in high yield. Arylboronates thus prepared, have been directly used in the Suzuki–Miyaura coupling reaction with different aryl halides and benzyl halides in a convenient one-pot, two-step solvent free green synthesis of unsymmetrical biaryls and diarylmethanes.
    钯纳米粒子 PEG中产生的催化剂催化 bis(pinacolato)diboron 与各种 芳基/卤代苄 负担 芳基硼酸苄基酯产率高。如此制备的芳基硼酸酯已直接用于Suzuki-Miyaura与不同的芳基卤化物和卤代苄 一锅两步 溶剂 不对称的游离绿色合成 联芳基 和 二芳基甲烷。
  • Discovery of Soticlestat, a Potent and Selective Inhibitor for Cholesterol 24-Hydroxylase (CH24H)
    作者:Tatsuki Koike、Masato Yoshikawa、Haruhi Kamisaki Ando、William Farnaby、Toshiya Nishi、Etsurou Watanabe、Jason Yano、Maki Miyamoto、Shigeru Kondo、Tsuyoshi Ishii、Takanobu Kuroita
    DOI:10.1021/acs.jmedchem.1c00864
    日期:2021.8.26
    to 24S-hydroxycholesterol (24HC). Despite a wide range of potential of CH24H as a drug target, no potent and selective inhibitors have been identified. Here, we report on the structure-based drug design (SBDD) of novel 4-arylpyridine derivatives based on the X-ray co-crystal structure of hit derivative 1b. Optimization of 4-arylpyridine derivatives led us to identify 3v ((4-benzyl-4-hydroxypiperidin-1-yl)(2
    胆固醇24-羟化酶(CH24H,CYP46A1)是一种大脑特异性细胞色素P450(CYP)家族酶,通过将胆固醇转化为24S-羟基胆固醇(24HC),在脑胆固醇稳态中发挥作用。尽管 CH24H 作为药物靶点具有广泛的潜力,但尚未发现有效的选择性抑制剂。在这里,我们报告了基于hit衍生物1b的X射线共晶结构的新型4-芳基吡啶衍生物的基于结构的药物设计(SBDD)。 4-芳基吡啶衍生物的优化使我们确定3v ((4-benzyl-4-羟基哌啶-1-基)(2,4'-联吡啶-3-基)甲酮,IC 50 = 7.4 nM) 是一种高效、选择性、脑渗透性 CH24H 抑制剂。小鼠口服3v后,大脑中 24HC 水平呈剂量依赖性降低(1、3 和 10 mg/kg)。化合物3v (soticlestat,也称为 TAK-935)目前正在临床研究中,作为治疗癫痫的新型药物类别,用于治疗 Dravet 综合征和 Lennox-Gastaut
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐